Patents by Inventor John Lincecum

John Lincecum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treating neurological disorders
    Patent number: 9775899
    Abstract: Methods of treating neuronal disorders, such as mechanical neuronal traumas and neurodegenerative disorders, with TWEAK or a TWEAK receptor blocking agents are presented.
    Type: Grant
    Filed: December 18, 2012
    Date of Patent: October 3, 2017
    Assignee: Biogen MA Inc.
    Inventors: Linda C. Burkly, Kyungmin Hahm, Timothy Zheng, Steve Perrin, John Lincecum
  • Targeting of T-lymphocytes to treat amyotrophic lateral sclerosis
    Patent number: 8946301
    Abstract: Methods and therapeutic compositions are disclosed for treating neurodegenerative disorders and, in particular Amyotrophic Lateral Sclerosis, using sphingosine1-phosphate receptor modulators, such as fingolimod or a pharmaceutically acceptable salt, hydrate, or solvate thereof.
    Type: Grant
    Filed: November 29, 2012
    Date of Patent: February 3, 2015
    Assignee: ALS Therapy Development Institute
    Inventors: Steven Perrin, John Lincecum, Alan Gill, Fernando Vieira
  • Targeting of CD8+ T-lymphocytes to treat neurodegenerative diseases
    Patent number: 8673308
    Abstract: Methods and therapeutic agents are disclosed for treating neurodegenerative disorders by depletion of CD8 positive T cells by using antibodies, FAb fragments of antibodies or similar agents that sequester, neutralize or deplete the CD8+ cytotoxic T cells.
    Type: Grant
    Filed: February 23, 2012
    Date of Patent: March 18, 2014
    Assignee: ALS Therapy Development Institute
    Inventors: Steven Perrin, John Lincecum, Alan Gill, Fernando Vieira
  • TARGETING OF CD8+ T-LYMPHOCYTES TO TREAT NEURODEGENERATIVE DISEASES
    Publication number: 20120237505
    Abstract: Methods and therapeutic agents are disclosed for treating neurodegenerative disorders by depletion of CD8 positive T cells by using antibodies, FAb fragments of antibodies or similar agents that sequester, neutralize or deplete the CD8+ cytotoxic T cells.
    Type: Application
    Filed: February 23, 2012
    Publication date: September 20, 2012
    Applicant: ALS Therapy Development Institute
    Inventors: Steven Perrin, John Lincecum, Alan Gill, Fernando Vieira
  • TREATING NEUROLOGICAL DISORDERS
    Publication number: 20120183542
    Abstract: Methods of treating neuronal disorders, such as mechanical neuronal traumas and neurodegenerative disorders, with TWEAK or a TWEAK receptor blocking agents are presented.
    Type: Application
    Filed: August 31, 2011
    Publication date: July 19, 2012
    Inventors: Linda C. Burkly, Kyungmin Hahm, Timothy Zheng, Steve Perrin, John Lincecum
  • TREATING NEUROLOGICAL DISORDERS
    Publication number: 20090124993
    Abstract: Methods of treating neuronal disorders, such as mechanical neuronal traumas and neurodegenerative disorders, with TWEAK or TWEAK-R blocking agents are presented.
    Type: Application
    Filed: February 17, 2006
    Publication date: May 14, 2009
    Inventors: Linda C. Burkly, Kyungmin Hahm, Timothy Zheng, Steve Perrin, John Lincecum